Sutro Biopharma Inc (STRO)

Jun 17, 2025

Sutro Biopharma (NASDAQ:STRO) Upgraded to Overweight at Piper Sandler - Defense World

Jun 17, 2025

Jun 16, 2025

Sutro Biopharma (STRO) Receives Upgrade to Overweight by Piper S - GuruFocus

Jun 16, 2025

Jun 16, 2025

Piper Sandler Upgrades Sutro Biopharma to Overweight From Neutral, $2 Price Target - MarketScreener

Jun 16, 2025

Jun 16, 2025

Sutro Biopharma (STRO) Receives Upgrade with Promising Drug Prospects | STRO Stock News - GuruFocus

Jun 16, 2025

Jun 16, 2025

Piper Sandler upgrades Sutro Biopharma stock rating on pipeline progress By Investing.com - Investing.com Canada

Jun 16, 2025

Jun 16, 2025

Bank of America Corp DE Sells 22,894 Shares of Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World

Jun 16, 2025

Jun 16, 2025

Sutro Biopharma, Inc. (NASDAQ:STRO) Given Consensus Rating of “Hold” by Analysts - Defense World

Jun 16, 2025

Jun 15, 2025

Piper Sandler Upgrades Sutro Biopharma (STRO) to Overweight | ST - GuruFocus

Jun 15, 2025

Jun 09, 2025

Sutro Biopharma, Inc. (NASDAQ:STRO) Stock Position Decreased by Two Sigma Investments LP - Defense World

Jun 09, 2025

Jun 07, 2025

Sutro Biopharma, Inc. (NASDAQ:STRO) Shares Sold by Millennium Management LLC - Defense World

Jun 07, 2025

Jun 05, 2025

ProShare Advisors LLC Boosts Holdings in Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World

Jun 05, 2025

Jun 03, 2025

Nuveen Asset Management LLC Acquires 124,154 Shares of Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World

Jun 03, 2025

Jun 03, 2025

Sutro Biopharma names Greg Chow as new CFO - Investing.com

Jun 03, 2025

Jun 02, 2025

Sutro Biopharma (STRO) Appoints New CFO Greg Chow | STRO Stock N - GuruFocus

Jun 02, 2025

Jun 02, 2025

Sutro Biopharma names Greg Chow as new CFO By Investing.com - Investing.com Canada

Jun 02, 2025

Jun 02, 2025

Sutro Biopharma Appoints Greg Chow as Chief Financial Officer - The Manila Times

Jun 02, 2025

Jun 02, 2025

Sutro Biopharma Strengthens ADC Leadership: New CFO Brings $225M Capital Raising Track Record - Stock Titan

Jun 02, 2025

Jun 02, 2025

Two Sigma Advisers LP Has $1.01 Million Stock Holdings in Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World

Jun 02, 2025

May 29, 2025

Northern Trust Corp Buys 14,492 Shares of Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World

May 29, 2025

May 28, 2025

BNP Paribas Financial Markets Buys 68,234 Shares of Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World

May 28, 2025

May 27, 2025

Sutro Biopharma’s SWOT analysis: stock shifts focus amid pipeline changes By Investing.com - Investing.com Nigeria

May 27, 2025

May 26, 2025

Sutro Biopharma’s SWOT analysis: stock shifts focus amid pipeline changes - Investing.com

May 26, 2025

May 23, 2025

Sutro Biopharma unveils best-in-class anti-tissue factor ADC - BioWorld MedTech

May 23, 2025

May 22, 2025

Sutro Biopharma, Inc. (NASDAQ:STRO) Given Consensus Rating of “Hold” by Brokerages - Defense World

May 22, 2025

May 20, 2025

Sutro Biopharma (NASDAQ:STRO) Price Target Cut to $0.80 by Analysts at Bank of America - Defense World

May 20, 2025

May 19, 2025

Sutro Biopharma (STRO): Analyst Lowers Price Target by 20% | STR - GuruFocus

May 19, 2025

May 19, 2025

Bank of America Adjusts Sutro Biopharma (STRO) Price Target | ST - GuruFocus

May 19, 2025

May 15, 2025

Dimensional Fund Advisors LP Buys 156,139 Shares of Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World

May 15, 2025

May 14, 2025

Sutro Biopharma Reports Q1 2025 Earnings and Restructuring - TipRanks

May 14, 2025

May 14, 2025

Transcript : Sutro Biopharma, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 04 - marketscreener.com

May 14, 2025

May 12, 2025

Sutro Biopharma Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 12, 2025

May 12, 2025

Sutro Biopharma, Inc. (NASDAQ:STRO) Shares Sold by Barclays PLC - Defense World

May 12, 2025

May 10, 2025

Sutro Biopharma Inc Reports Q1 2025 Revenue of $17.4M, Exceeding Estimates; EPS at -$0.91, Missing Projections - GuruFocus

May 10, 2025

May 10, 2025

Sutro Biopharma First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

May 10, 2025

May 09, 2025

Sutro Biopharma, Inc. (STRO) Reports Q1 Loss, Tops Revenue Estimates - NewsBreak: Local News & Alerts

May 09, 2025

May 09, 2025

Sutro Biopharma earnings missed by $0.06, revenue topped estimates - Investing.com Canada

May 09, 2025

May 09, 2025

Sutro Biopharma Reports First Quarter 2025 Financial Results and Business Highlights - The Manila Times

May 09, 2025

May 08, 2025

Sutro Biopharma Reports First Quarter 2025 Financial Results and Business Highlights | STRO Stock News - GuruFocus

May 08, 2025

May 08, 2025

Sutro Biopharma, Inc. Advances ADC Pipeline Focus with Promising Preclinical Results and Strategic Reprioritization - Nasdaq

May 08, 2025

May 07, 2025

Financial Metrics Check: Sutro Biopharma Inc (STRO)’s Ratios for Trailing Twelve Months - DWinneX

May 07, 2025

May 06, 2025

Sutro Biopharma, Inc. (NASDAQ:STRO) Shares Bought by Invesco Ltd. - Defense World

May 06, 2025

May 02, 2025

Sutro Biopharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Globe and Mail

May 02, 2025

May 02, 2025

Sutro Biopharma (NASDAQ:STRO) Earns Neutral Rating from HC Wainwright - The AM Reporter

May 02, 2025

May 01, 2025

Sutro Biopharma to Participate in Upcoming Investor Conferences - The Manila Times

May 01, 2025

May 01, 2025

Leading ADC Developer Sutro Biopharma to Present at Citizens and BofA Healthcare Conferences in May - Stock Titan

May 01, 2025

May 01, 2025

New Cancer Treatments Spark Hope as Traditional Funding Faces Uncertainty - Benzinga

May 01, 2025

May 01, 2025

Sutro Biopharma (NASDAQ:STRO) Earns “Neutral” Rating from HC Wainwright - Defense World

May 01, 2025

Apr 30, 2025

Taking the lead: Sutro Biopharma Inc (STRO) - Sete News

Apr 30, 2025